PRESS RELEASE published on 05/01/2023 at 14:00, 1 year 4 months ago Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
PRESS RELEASE published on 04/24/2023 at 14:00, 1 year 5 months ago Salix Partners with the Colorectal Cancer Alliance on Community Screening Program
PRESS RELEASE published on 04/13/2023 at 14:00, 1 year 5 months ago Bausch Health to Announce First-Quarter 2023 Results on May 4
PRESS RELEASE published on 04/04/2023 at 14:00, 1 year 5 months ago New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider
PRESS RELEASE published on 03/01/2023 at 14:00, 1 year 6 months ago Bausch Health Announces Changes to its Board of Directors
PRESS RELEASE published on 02/23/2023 at 13:00, 1 year 7 months ago Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
PRESS RELEASE published on 02/13/2023 at 14:00, 1 year 7 months ago Salix Announces 2023 Gastrointestinal Health Scholars Program
PRESS RELEASE published on 02/01/2023 at 14:00, 1 year 7 months ago Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
Published on 09/28/2024 at 02:06, 22 hours 18 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 22 hours 24 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 22 hours 24 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 10 hours 22 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 1 hour ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 2 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 5 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 6 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 6 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 6 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 6 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024